{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:45:43Z","timestamp":1760057143224,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ajem.2008.11.012","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T05:45:00Z","timestamp":1250228700000},"page":"903.e1-903.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Trastuzumab (Herceptin)\u2013associated cardiomyopathy presented as new onset of complete left bundle-branch block mimicking acute coronary syndrome: a case report and literature review"],"prefix":"10.1016","volume":"27","author":[{"given":"Chung-Ming","family":"Tu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Mung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-been","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2008.11.012_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.11.012_bib2","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.11.012_bib3","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.11.012_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa053028","article-title":"Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer","volume":"354","author":"Joensuu","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.11.012_bib5","first-page":"S5","volume":"94","author":"Slamon","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.ajem.2008.11.012_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10637-005-2899-8","article-title":"Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer","volume":"23","author":"Yeon","year":"2005","journal-title":"Invest New Drugs"},{"issue":"3","key":"10.1016\/j.ajem.2008.11.012_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.breast.2003.09.002","article-title":"Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer","volume":"13","author":"Suter","year":"2004","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.ajem.2008.11.012_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2146\/ajhp050549","article-title":"Trastuzumab and cardiotoxicity: weighing the risks","volume":"63","author":"Wong","year":"2006","journal-title":"Am J Health Syst Pharm"},{"issue":"3 Suppl 11","key":"10.1016\/j.ajem.2008.11.012_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/sonc.2002.34051","article-title":"Trastuzumab cardiotoxicity: speculations regarding pathophysiology and targets for further study","volume":"29","author":"Schneider","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ajem.2008.11.012_bib10","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajem.2008.11.012_bib11","first-page":"60","article-title":"Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)","volume":"26","author":"Sliwkowski","year":"1999","journal-title":"Semin Oncol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675708008000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675708008000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:12:18Z","timestamp":1760022738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675708008000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0735675708008000"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2008.11.012","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trastuzumab (Herceptin)\u2013associated cardiomyopathy presented as new onset of complete left bundle-branch block mimicking acute coronary syndrome: a case report and literature review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2008.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}